Skip to main content Skip to footer

News & Inisghts

Diagnostic Database

Diagnostics 101
Digital Cognitive Assessments
- About Digital Cognitive Assessments
- DCA Performance Standards
CSF & PET
Blood-Based Biomarkers

Diagnostics 101
Digital Cognitive Assessments
- About Digital Cognitive Assessments
- DCA Performance Standards
CSF & PET
Blood-Based Biomarkers

News & Inisghts

Diagnostic Database

Diagnostics 101
Digital Cognitive Assessments
- About Digital Cognitive Assessments
- DCA Performance Standards
CSF & PET
Blood-Based Biomarkers

Category: Education

October 1, 2024
Blood biomarkers have emerged as accessible, cost-effective, and highly promising tools for advancing the diagnostics of Alzheimer’s disease. However, transitioning…
September 13, 2024
August 22, 2024
August 7, 2024
August 6, 2024
August 2, 2024
July 30, 2024
July 28, 2024
May 10, 2024
February 21, 2024
The internet is abuzz with claims that biomarker blood tests are the key to predicting dementia 15 years out. Here's…

←
1
2
3
→

Follow Us

Useful Links

Blood Test Performance Database
Diagnostics 101
Blood-Based Biomarkers
Digital Cognitive Assessments
CSF & PET

support

News & Insights
About Us
Contact Us

© 2025 UsAgainstAlzheimer’s. All rights reserved.

The Global CEO Initiative on Alzheimer’s Disease (CEOi) is a collaboration of leading private sector organizations dedicated to accelerating progress in the fight against Alzheimer's disease. By leveraging the collective influence of its members, CEOi works to shape global dialog, drive innovations in diagnostics and treatment, and increase global awareness of Alzheimer's.

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively.